- VOL 13. ISSUE 38
December 16, 2013
SEARCH NEWS & VIEWS
Study Finds Emerging Bird Flu Strain Is Still Poorly Adapted for Infecting Humans
Letter from the President
Compound Dramatically Reduces Joint Inflammation
NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT
FOLLOW US
Study Finds Emerging Bird Flu Strain Is Still Poorly Adapted for Infecting Humans
Despite initial studies to the contrary, the avian influenza virus H7N9 is still mainly adapted for infecting birds, not humans.
Letter from the President
Michael A. Marletta, president and CEO of The Scripps Research Institute, sends his holiday greetings and reflects on the institute’s accomplishments in 2013.
Compound Dramatically Reduces Joint Inflammation
The new drug candidate from the Griffin lab could provide doctors with additional treatment options for patients with rheumatoid arthritis who do not respond well to current therapies.
- TSRI Team Achieves Most Detailed Picture Ever of Key Part of Hepatitis C Virus
- Inside the Second Genetic Code: An Interview with Paul Schimmel
- Researchers Capture Structure of Key Part of Deadly Nipah Virus
- Clinical Trial Indicates Gabapentin Is Safe and Effective for Treating Alcohol Dependence
- Scientists Capture Most Detailed Picture Yet of Key AIDS Protein
- Preclinical Study Offers Hope for New Approach to Controlling HIV
- New Eye Treatment Effective in Laboratory Tests
- Eat More, Weigh Less: Worm Study Provides Clues to Better Fat-Loss Therapies for Humans
- New Strategy to Treat Multiple Sclerosis Shows Promise in Mice
- New Map of Insulin Pathway Could Lead to Better Diabetes Drugs
- Scientists Develop New Process to Create Artificial Cell Membranes
- TSRI’s Phil Baran Named MacArthur Fellow
- Team Discovers Important Wound-Healing Process
- Scientists Create Extremely Potent and Improved New Derivatives of Successful Anticancer Drug
- Team Solves Century-Old Chemistry Problem